Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia
Authors
Keywords
-
Journal
LEUKEMIA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-10-15
DOI
10.1038/s41375-019-0596-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A quantitative analysis of heterogeneities and hallmarks in acute myelogenous leukaemia
- (2019) C. W. Hu et al. Nature Biomedical Engineering
- BCL11A and MDR1 expressions have prognostic impact in patients with acute myeloid leukemia treated with chemotherapy
- (2018) Guo Xutao et al. PHARMACOGENOMICS
- High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemia
- (2018) Miriam Marquis et al. Blood Cancer Journal
- S100A4 May Be a Good Prognostic Marker and a Therapeutic Target for Colon Cancer
- (2018) Sabahattin Destek et al. Journal of Oncology
- miR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells
- (2016) Eric R. Lechman et al. CANCER CELL
- Multilevel Changes in Protein Dynamics upon Complex Formation of the Calcium-Loaded S100A4 with a Nonmuscle Myosin IIA Tail Fragment
- (2016) Gyula Pálfy et al. CHEMBIOCHEM
- Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9
- (2016) Rebekka K Schneider et al. NATURE MEDICINE
- Impact of genomics in the clinical management of patients with cytogenetically normal acute myeloid leukemia
- (2015) Brunangelo Falini et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- A structured proteomic approach identifies 14-3-3Sigma as a novel and reliable protein biomarker in panel based differential diagnostics of liver tumors
- (2015) Henning Reis et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- hnRNP K Is a Haploinsufficient Tumor Suppressor that Regulates Proliferation and Differentiation Programs in Hematologic Malignancies
- (2015) Miguel Gallardo et al. CANCER CELL
- Clinical significance ofin vivocytarabine-induced gene expression signature in AML
- (2015) Jatinder K. Lamba et al. LEUKEMIA & LYMPHOMA
- BloodSpot: a database of gene expression profiles and transcriptional programs for healthy and malignant haematopoiesis
- (2015) Frederik Otzen Bagger et al. NUCLEIC ACIDS RESEARCH
- Cytosine modifications in myeloid malignancies
- (2015) Kristen M. Meldi et al. PHARMACOLOGY & THERAPEUTICS
- Emerging Roles for hnRNPs in post-transcriptional regulation: what can we learn from flies?
- (2014) Luca Lo Piccolo et al. CHROMOSOMA
- S100A4 Is an Independent Prognostic Factor for Patients with Lung Cancer: A Meta-Analysis
- (2014) Hao Bai et al. Genetic Testing and Molecular Biomarkers
- NFI Transcription Factors Interact with FOXA1 to Regulate Prostate-Specific Gene Expression
- (2014) Magdalena M. Grabowska et al. MOLECULAR ENDOCRINOLOGY
- RNA interference targeting inhibition of S100A4 suppresses cell growth and promotes apoptosis in human laryngeal carcinoma Hep-2 cells
- (2014) JIA LIU et al. Molecular Medicine Reports
- Prognostic value of cytoplasmic expression of S100A4 protein in endometrial carcinoma
- (2014) HYE IN CHONG et al. ONCOLOGY REPORTS
- Ilf3 and NF90 functions in RNA biology
- (2014) Sandrine Castella et al. Wiley Interdisciplinary Reviews-RNA
- Comparing cancer vs normal gene expression profiles identifies new disease entities and common transcriptional programs in AML patients
- (2013) N. Rapin et al. BLOOD
- Acute myeloid leukaemia in adults
- (2013) Felicetto Ferrara et al. LANCET
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- S100A4 interacts with p53 in the nucleus and promotes p53 degradation
- (2013) L M Orre et al. ONCOGENE
- Posttranslational regulation of self-renewal capacity: insights from proteome and phosphoproteome analyses of stem cell leukemia
- (2012) M. Trost et al. BLOOD
- Functions of S100 Proteins
- (2012) R. Donato et al. CURRENT MOLECULAR MEDICINE
- The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemia
- (2012) Versha Banerji et al. JOURNAL OF CLINICAL INVESTIGATION
- γ-Catenin is overexpressed in acute myeloid leukemia and promotes the stabilization and nuclear localization of β-catenin
- (2012) R G Morgan et al. LEUKEMIA
- Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia
- (2012) Alex Kentsis et al. NATURE MEDICINE
- Insights into the regulation of protein abundance from proteomic and transcriptomic analyses
- (2012) Christine Vogel et al. NATURE REVIEWS GENETICS
- New Fusion Transcripts Identified in Normal Karyotype Acute Myeloid Leukemia
- (2012) Hongxiu Wen et al. PLoS One
- Assessing quality and completeness of human transcriptional regulatory pathways on a genome-wide scale
- (2011) Evgeny Shmelkov et al. Biology Direct
- Nucleolar proteins with altered expression in leukemic cell lines
- (2011) Kaisa J. Teittinen et al. LEUKEMIA RESEARCH
- The Epithelial-Mesenchymal Transition Mediator S100A4 Maintains Cancer-Initiating Cells in Head and Neck Cancers
- (2010) J.-F. Lo et al. CANCER RESEARCH
- Sumoylation and Nuclear Translocation of S100A4 Regulate IL-1β-mediated Production of Matrix Metalloproteinase-13
- (2010) Keally J. Miranda et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Expression of S100A8 in leukemic cells predicts poor survival in de novo AML patients
- (2010) E Nicolas et al. LEUKEMIA
- Phosphoproteomic Analysis of Human Embryonic Stem Cells
- (2009) Laurence M. Brill et al. Cell Stem Cell
- Complexity of CEBPA Dysregulation in Human Acute Myeloid Leukemia
- (2009) T. Pabst et al. CLINICAL CANCER RESEARCH
- Functional proteomic profiling of AML predicts response and survival
- (2008) S. M. Kornblau et al. BLOOD
- An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephase
- (2008) Alexander Kohlmann et al. BRITISH JOURNAL OF HAEMATOLOGY
- S100A4 overexpression proves to be independent marker for breast cancer progression
- (2008) Nawfal I Ismail et al. Cancer Cell International
- Tumor associated antigen PRAME is a marker of favorable prognosis in childhood acute myeloid leukemia patients and modifies the expression of S100A4, Hsp 27, p21, IL-8 and IGFBP-2in vitroandin vivo
- (2008) Nicolas Tajeddine et al. LEUKEMIA & LYMPHOMA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now